ADDvise Group Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Staffan Torstensson

İcra Kurulu Başkanı

SEK 300.0k

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	less than a year
CEO sahipliği	n/a
Yönetim ortalama görev süresi	less than a year
Yönetim Kurulu ortalama görev süresi	3.8yrs

Son yönetim güncellemeleri

Recent updates

CEO

Staffan Torstensson (52 yo)

less than a year

Görev süresi

SEK 300,000

Tazminat

Mr. Staffan Torstensson is Chief Executive Officer of ADDvise Group AB (publ) from September 1, 2024 and servers as its Director. Mr. Torstensson was Independent Chairman of ADDvise Group AB (publ) from Ap...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Staffan Torstensson	CEO & Director	less than a year	SEK 300.00k	Veri yok
Johan Irwe	Interim Chief Financial Officer	less than a year	Veri yok	Veri yok
Hanna Myhrman	General Counsel and Head of M&A	4yrs	Veri yok	0.015% SEK 110.6k
Fredrik Mella	Head of Heatlhcare & Senior VP	1.9yrs	Veri yok	0.13% SEK 977.2k
Johan Seltborg	Head of Lab	less than a year	Veri yok	Veri yok

0.8yrs

Ortalama Görev Süresi

50yo

Ortalama Yaş

Deneyimli Yönetim: ADDV B 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 0.8 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Staffan Torstensson	CEO & Director	4.6yrs	SEK 300.00k	Veri yok
Anna Ljung	Director	2.5yrs	SEK 200.00k	Veri yok
Fredrik Celsing	Independent Chairman	8.8yrs	SEK 100.00k	0.057% SEK 412.1k
Johanne Braendgaard	Independent Director	3.8yrs	SEK 100.00k	Veri yok
Thomas Eklund	Director	less than a year	Veri yok	0.85% SEK 6.2m

3.8yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ADDV B 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.8 yıldır).

ADDvise Group Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

ADDvise Group AB (publ), Annual General Meeting, May 06, 2025

ADDvise Group AB (publ) Announces Chief Financial Officer Changes

Addvise Group AB (Publ) Announces Chief Executive Officer Changes

Addvise Group AB (Publ) Announces Erland Pontusson Decline Re-Election from the Board

ADDvise Group AB (publ) Announces Management Changes

Addvise Group AB (Publ) Appoints Oliver Humlen as Member of the Executive Management Team

Recent updates

ADDvise Announces Restructuring of its Two Existing Business Areas

ADDvise Group AB (publ) to Report Q1, 2025 Results on Apr 16, 2025

ADDvise Group AB (publ), Annual General Meeting, May 06, 2025

ADDvise Group AB (publ) Announces Chief Financial Officer Changes

Addvise Group AB (Publ) Announces Chief Executive Officer Changes

ADDvise Group AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 100 million.

Addvise Group AB (Publ) Announces Erland Pontusson Decline Re-Election from the Board

ADDvise Group AB (publ) (OM:ADDV A) acquired Axelerist, Inc. for $29.4 million.

ADDvise Group AB (publ) to Report First Half, 2024 Results on Jul 18, 2024

ADDvise Group AB (publ) (OM : ADDV A) completed the acquisition of Diabetic Supply Inc.

ADDvise Group AB (publ) Announces Management Changes

Addvise Group AB (Publ) Appoints Oliver Humlen as Member of the Executive Management Team

ADDvise Group AB (publ) Provides Earnings Guidance for the Year 2023

ADDvise Group AB (publ) (OM:ADDV A) signed a Letter of Intent to acquire Innovative Endoscopy Components, L.L.C. for $11.75? million.

ADDvise Group AB (publ) (OM:ADDV A) has signed a Letter of Intent to acquire Kolplast CI S.A. for approximately BRL 210 million.

ADDvise Group AB (publ) (OM:ADDV A) signed a letter of intent to acquire X-Ray Cassette Repair Company, Inc. for approximately $15 million.

ADDvise Group Appoints Fredrik Mella as Senior Vice President Alongside His Current Role as Chief Operating Officer

ADDvise Group AB (publ) to Report Fiscal Year 2022 Final Results on Apr 05, 2023

ADDvise Group AB (publ), Annual General Meeting, May 05, 2023

ADDvise Group AB (publ) (OM:ADDV A) entered into a letter of intent to acquire Clinichain Holding B.V. for €33.80 million.

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of Seebreath AB from the shareholders.

ADDvise Group AB (publ) Announces Executive Changes

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of Surplus Diabetic, Inc for $19.5 million.

Addvise Group AB (Publ) Not to Propose Any Dividend for the Financial Year 2021

ADDvise Group AB (publ) (OM:ADDV A) signed a Letter of Intent to acquire Surplus Diabetic, Inc. for $19.5 million.

ADDvise Group AB (publ) (OM:ADDV A) signed a Letter of Intent to acquire Zevex Physical Evaluation for $7.3 million.

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of Southern Life Systems, Inc.

ADDvise Group AB (Publ) Provides Earnings Guidance for the Financial Year 2022

ADDvise Group AB (publ) (OM:ADDV A) signed a Letter of Intent to acquire Southern Life Systems, Inc. for $11 million.

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of Medisuite, LLC.

ADDvise Group AB (publ) (OM:ADDV A) completed the acquisition of MRC Systems Ltd.

ADDvise Group AB (publ) (OM:ADDV A) signed a letter of intent to acquire Medisuite, LLC for $10.3 million.

ADDvise Group AB (publ) (OM:ADDV A) signed a letter of intent to acquire Graham Medical Technologies, LLC for $5.8 million.

ADDvise Group AB (publ) has announced a Derivatives Offering in the amount of SEK 27.977487 million.

ADDvise Group AB (publ) (OM:ADDV A) signed a Letter of Intent to acquire MRC Systems Ltd for $8 million.

ADDvise Group AB Announces Nomination Committee

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş